Prelude Capital Management, LLC Biora Therapeutics, Inc. Call Options Transaction History

Prelude Capital Management, LLC

  • $1.57 Billion
  • Q3 2024

Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 16, 2022
SELL
$1.11 - $2.25 $13,098 - $26,550
-11,800 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$1.35 - $4.89 $15,930 - $57,701
11,800 New
11,800 $25,000

Others Institutions Holding BIOR

# of Institutions
2
Shares Held
890
Call Options Held
0
Put Options Held
0
View Full List

About BIORA THERAPEUTICS, INC.

BIOR Quotes by TradingView
  • Ticker BIOR
  • Exchange NASDAQ
  • Shares Outstandng 186,623,605
  • Market Cap $312M
  • Description
  • Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ing...
More about BIOR
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email